5 completed. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
Follow anacetrapib: new trials by email Literature Review of anacetrapib trials Research Report on anacetrapib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038) anacetrapib - Dyslipidemia | Phase 1 | Completed | Merck Sharp & Dohme LLC | 24 | 2010-06-01 | 2015-08-14 |
| Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039) anacetrapib - Dyslipidemia | Phase 1 | Completed | Merck Sharp & Dohme LLC | 24 | 2010-05-01 | 2015-10-14 |
| The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3) anacetrapib, Comparator: atorvastatin, Comparator: placebo to MK0859 - Dyslipidemia | Phase 1 | Completed | Merck Sharp & Dohme LLC | 46 | 2009-11-01 | 2015-06-04 |
| A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED) MK0859 - Hypercholesterolemia, Hyperlipidemia | Phase 1 | Completed | Merck Sharp & Dohme LLC | 50 | 2006-07-01 | 2015-02-25 |
| A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED) MK0859 - Ambulatory Blood Pressure | Phase 1 | Completed | Merck Sharp & Dohme LLC | 22 | 2006-07-01 | 2015-02-27 |
Dyslipidemias (3) · Hepatic Insufficiency (1) · Hypercholesterolemia (1) · Hyperlipidemias (1) · Renal Insufficiency (1)